abstract |
Striatal neurodegenerative disorders, e.g. Parkinson's disease, are treated by administration of an effective dose of an antioxidant compound of formula I, formula II or a pharmaceutically acceptable salt thereof, in a regimen that decreases the adverse effects of the disorder. Such adverse effects can motor deficits, which include catalepsy or akinesia. Also provided are kits and systems for practicing the subject methods, as well as methods of use of agents identified in the screening method of the invention. |